Article info

Download PDFPDF
Extended report
Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis

Authors

  1. Correspondence to Dr Jörg H W Distler, Department of Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Ulmenweg 18, D91054 Erlangen, Germany; joerg.distler{at}uk-erlangen.de
View Full Text

Citation

Huang J, Maier C, Zhang Y, et al
Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis

Publication history

  • Received November 14, 2016
  • Revised May 29, 2017
  • Accepted July 18, 2017
  • First published August 16, 2017.
Online issue publication 
October 09, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.